Back to search

Article

Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial

2022-08-03

Abstract excerpt

<h4>Background</h4> Children with sickle cell anemia in areas of Africa with endemic malaria transmission are commonly prescribed malaria chemoprevention. The comparative efficacy of prevention regimens is largely unknown. <h4>Methods and Findings</h4> We enrolled Kenyan children aged 1-10 years with HbSS in a randomized, open-label trial conducted between January 23, 2018, and December 15, 2020, in Homa Bay, Keny...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1548b46a-feba-5d95-ac51-9ba0b4a5b668
DOI
10.1101/2022.08.02.22278335
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trialDOI 10.1101/2022.08.02.22278335
Select a neighboring publication to make it the new centre.